Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB. Musoke P, et al. Among authors: bagenda d. AIDS. 1999 Mar 11;13(4):479-86. doi: 10.1097/00002030-199903110-00006. AIDS. 1999. PMID: 10197376 Clinical Trial.
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F. Jackson JB, et al. Among authors: bagenda d. Lancet. 2003 Sep 13;362(9387):859-68. doi: 10.1016/S0140-6736(03)14341-3. Lancet. 2003. PMID: 13678973 Clinical Trial.
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB. Guay LA, et al. Among authors: bagenda d. Lancet. 1999 Sep 4;354(9181):795-802. doi: 10.1016/S0140-6736(99)80008-7. Lancet. 1999. PMID: 10485720 Free article. Clinical Trial.
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, Eshleman SH. Church JD, et al. Among authors: bagenda d. AIDS Res Hum Retroviruses. 2009 Jul;25(7):673-7. doi: 10.1089/aid.2009.0003. AIDS Res Hum Retroviruses. 2009. PMID: 19552593 Free PMC article.
Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda.
Onyango-Makumbi C, Bagenda D, Mwatha A, Omer SB, Musoke P, Mmiro F, Zwerski SL, Kateera BA, Musisi M, Fowler MG, Jackson JB, Guay LA. Onyango-Makumbi C, et al. Among authors: bagenda d. J Acquir Immune Defic Syndr. 2010 Jan;53(1):20-7. doi: 10.1097/QAI.0b013e3181bdf68e. J Acquir Immune Defic Syndr. 2010. PMID: 19779355 Free PMC article. Clinical Trial.
Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.
Lubega IR, Fowler MG, Musoke PM, Elbireer A, Bagenda D, Kafulafula G, Ko J, Mipando L, Mubiru M, Kumwenda N, Taha T, Jackson JB, Guay L. Lubega IR, et al. Among authors: bagenda d. J Acquir Immune Defic Syndr. 2010 Sep;55(1):58-64. doi: 10.1097/QAI.0b013e3181db059d. J Acquir Immune Defic Syndr. 2010. PMID: 20588184 Free PMC article.
65 results